FDA Clears Tool To Help Diagnose Autism
Disability Scoop
The FDA has approved Neurora, a biometric tool that helps clinicians assess whether children aged 18 months to 12 years may have autism by analyzing video and audio data from behavioral evaluations. The device uses over 100 biometric indicators, such as facial expressions and eye gaze, to provide quantitative evidence to support diagnostic decisions. Neurora aims to enhance autism evaluations with objective data, complementing professional judgment rather than replacing it.
All articles from 27 October 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.